Journal of Bioenergetics and Biomembranes

, Volume 44, Issue 1, pp 179–188 | Cite as

Protective effect of Phyllanthus fraternus against mitochondrial dysfunction induced by co-administration of cisplatin and cyclophosphamide

  • Kavita K. Kumari
  • O. H. Setty


The evolving role of mitochondria, in mediating chemotherapy-induced apoptosis motivated us for the studies described here. The combination of cisplatin and cyclophosphamide is widely used in treating various types of cancers. The purpose of our study was to understand the mechanism of the toxicity induced by the co-administration of cisplatin and cyclophosphamide, on mitochondrial bioenergetics, and to study the protective effect of prior administration of the medicinal plant extract Phyllanthus fraternus. Our results reveal that co-administration of cisplatin (12 mg/kg, i.p) and cyclophosphamide (150 mg/kg, oral) to wistar rats (100 g) significantly alters mitochondrial structure and hence function. The rate of mitochondrial respiration was decreased significantly with both NAD + and FAD-linked substrates. The respiratory control ratio, an index of membrane integrity and the P/O ratio, a measure of phosphorylating efficiency also were decreased significantly accompanied by elevation in the lipid peroxide levels in liver, kidney homogenate and liver mitochondria respectively. Also, the phospholipid content of the mitochondrial membrane, showed a significant decrease, indicating mitochondrial membrane changes. Prior administration of an aqueous extract of P. fraternus (100 mg/kg) to rats, showed protection on all parameters investigated. Administration of P. fraternus alone did not show any significant changes on mitochondrial membrane bioenergetics. Thus, we propose, that the toxic side effects of cisplatin + cyclophosphamide, are due to a chain of interconnected events, within the mitochondrial inner membrane, ultimately leading to hepatotoxicity and nephrotoxicity. Further, our work also suggests that administration of aqueous extract of P. fraternus can enhance the therapeutic potential of anticancer drugs by reducing drug related toxicity.


Cisplatin Cyclophosphamide Phyllanthus fraternus (P. fraternus) Mitochondria,RCR P/O ratio Free radicals Lipid peroxidation enzyme Succinate Cytochrome 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ali BH, Moundhri MS (2006) Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol 44:1173–1183, and their weapons. J Cell Physiol 2002;192:131–7CrossRefGoogle Scholar
  2. Anders MW, Robotham JL, Sheu SS (2006) Mitochondria: new drug targets for oxidative stress-induced diseases. Expert Opin Drug Metab Toxicol 2(1):71–79CrossRefGoogle Scholar
  3. Bhattacharjee R, Sil PC (2006) The protein fraction of Phyllanthus niruri plays a protective role against acetaminophen induced hepatic disorder via its antioxidant properties. Phytother Res 20(7):595–601CrossRefGoogle Scholar
  4. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem physiol 37:911–917CrossRefGoogle Scholar
  5. Calixto JB, Santos AR, Cechinel FV, Yunes RA (1998) Review of the Plants of the Genus Phyllanthus: Their Chemistry, Pharmacology, and Therapeutic Potential. Med Res Rev 8(4):225–258CrossRefGoogle Scholar
  6. Chatterjee M, Sil PC (2006) Hepatoprotective effect of aqueous extract of Phyllanthus niruri on nimesulide-induced oxidative stress in vivo. Indian J Biochem Biophys 43(5):299–305Google Scholar
  7. Cooperstein ST, Liazarow AJ (1951) A microspectrophotometric method for the determination of cytochrome c oxidase. J Biol Chem 189:665–670Google Scholar
  8. Custódio JB, Cardoso CM, Santos MS, Almeida LM, Vicente JA, Fernandes MA (2009) Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents. Toxicology 2,259(1–2):18–24CrossRefGoogle Scholar
  9. Davies MJ, Fu S, Dean RT (1995) Protein hydroperoxides can give rise to reactive free radicals. Biochem 305:643–649Google Scholar
  10. Estabrook RW (1967) Mitochondrial respiratory control and the polarographic measurements of ADP:O ratios. In: Estabrook RW, Pullman ME (eds) Methods in enzymology, 10th edn. Academic, New York, pp 41–47Google Scholar
  11. Fiske CH, Subba Row Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66:375–400Google Scholar
  12. Gemba M, Fukuishi N, Nakano S (1988) Effect of N-N-diphenyl-p-phenylenediamine pretreatment on urinary enzyme exctretion in cisplatin nephrotoxicity in rats. Jpn J Pharmacol 46:90–92Google Scholar
  13. Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuretic reaction. J Biol Chem 177:751–766Google Scholar
  14. Hanaki Y, Sugiyama S, Akiyamam N, OzawaT (1990) Role of the autonomic nervous system in cyclophosphamide induced heart mitochondrial dysfunction in rats. Biochem Int 21: 289–295Google Scholar
  15. Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47–61Google Scholar
  16. Hatefi Y, Reiske JS (1967) In: Estabrook RE, Pullman ME (eds) Methods in enzymology, 10. Academic, New York, pp 225–231Google Scholar
  17. Kameyama Y, Gemba M (1991) The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices. Jpn J Pharmacol 57: 259–262Google Scholar
  18. Kearney EB (1957) Studies on succinate dehydrogenase IV ACTIVATION OF THE BEEF HEART ENZYME. J Biol Chem 229:363–375Google Scholar
  19. King TE (1967) Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Estabrook RW, Pullman ME (eds) Methods in enzymology, 10. Academic press Inc, New York, pp 322–331Google Scholar
  20. King TE, Robert HL (1967) Preparation and properties of soluble NADH dehydrogenase from cardiac muscle. In: Estabrook RW, Pullman ME (eds) Methods in Enzymology, 10. Academic, Newyork, pp 275–294Google Scholar
  21. Kozel’tsev VL, Golubev VP, Volodina TV (1980) Protective role of phospholipids in the enzymatic degradation of mitochondrial membrane proteins. Vopr Med Khim 26(5):680–5Google Scholar
  22. Lawrence CB, Davis NT (1986) A novel simple and rapid method for the isolation of mitochondria which exibit respiratory control from small intestinal mucosa. Biochem Biophys Acta 848:35–40CrossRefGoogle Scholar
  23. Levrat C, Louisot P (1994) Study of the succinate dehydrogenase activation in permeabilized mitochondria through the Ca(2+)-stimulated phospholipase A2. Biochem Mol Biol Int 34(3):569–578Google Scholar
  24. Manjrekar AP, Jisha V, Bag PP, Adhikary B, Pai MM, Hegde A, Nandini M (2008) Effect of Phyllanthus niruri Linn. treatment on liver, kidney and testes in CCl4 induced hepatotoxic rats. Indian J Exp Biol 46(7):514–20Google Scholar
  25. Martins NM, Santos NAG, Curti C, Bianchi MLP, Santos AC (2008) Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J Appl Toxicol 28:337–344CrossRefGoogle Scholar
  26. Ogawa Y, Kondo T, Sugiyama S, Ogawa K, Satake T, Ozawa T (1987) Role of phospholipase in the genesis of doxorubicin-induced cardiomyopathy in rats. Cancer Res 47:1239–1243Google Scholar
  27. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Annal Biochem 95:351–358, 67CrossRefGoogle Scholar
  28. Padma P, Setty OH (1997) Protective effect of vitamin E against ethionine toxicity. Biochem Mol Biol Int 41:785–795Google Scholar
  29. Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C (2008) Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol 14:1491–1497Google Scholar
  30. Pompella A, Romani A, Benedetti A, Comporti M (1991) Loss of membrane protein thiols and lipid peroxidation in allyl alcohol hepatotoxicity. Biochem Pharmacol 41:1255–1259Google Scholar
  31. Pozzan T, Miconi V, Di Virgilio F, Azzone GF (1979) H+/site, charge/site, and ATP/site ratios at coupling sites I and II in mitochondrial e- transport. J Biol Chem 254:12000-12005Google Scholar
  32. Sailaja R, Setty OH (2006) Protective effect of Phyllanthus fraternus against allyl alcohol-induced oxidative stress in liver mitochondria. J Ethnopharmacol 21:105(1–2):201–9Google Scholar
  33. Sangeetha P, Das UN, Koratkar R, Suryaprabha P (1990) Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med 8: 15–19Google Scholar
  34. Santiago E, López-Moratalla N, Segovia JL, Eugui J (1977) NADH-cytochrome c reductase, succinate cytochrome c reductase and phospholipids. Rev Esp Fisiol 33(3):197–204Google Scholar
  35. Santos NAG, Martins NM, Curti C, Bianchi MLP, Santos AC (2007) Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of rats. Chem Biol Int 170:177–186CrossRefGoogle Scholar
  36. Sebastian T, Setty OH (1999) Protective effect of P.fraternus against ethanol induced mitochondrial function. Alcohol 17:29–34CrossRefGoogle Scholar
  37. Shanafelt TD, Lin T, Geyer SM et al (2007) Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia. Cancer 109(11):2291–2298CrossRefGoogle Scholar
  38. Simpson JA, Narita S, Gieseg S, Gebicki S, Gebicki JM, Dean RT (1992) Long-lived reactive species on free-radical-damaged proteins. Biochem J 282:621–624Google Scholar
  39. Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP (2000) Dose-dependent protection by lipoic acid against cisplatin induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol 86:234–241CrossRefGoogle Scholar
  40. Stankiewicz A, Skrzydlewska E, Makieła M (2002) Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol Drug Interact 19:67–82Google Scholar
  41. Sugihara KS, Nakano S, Koda M, Tanaka K, Fukuishi N, and Gemba M (1987) Stimulatory effect of cisplatin on production of lipid peroxidation in renal fissues. Jpn J Pharmacol 43: 247–252Google Scholar
  42. Sugiyama S, Hayakawa M, Kato T, Hanaki Y, Shimizu K, Ozawa T (1989) Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. Biochem Biophys Res Commun 159:1121–1127Google Scholar
  43. Supratim Ray, Chandana Sengupta, Kumal Roy (2005) Evaluation of Ascorbic acid as suppressor of cyclophospamide induced lipid peroxidation using common laboratory markers. Acta Poloniae Pharmaceutican Drug Res 62(2):145–151Google Scholar
  44. Szewczyk A, Wojtczak L (2002) Mitochondria as a pharmacological target. Pharmacol Rev 54:101–127CrossRefGoogle Scholar
  45. Tisdale HD (1967) In: Estabrook RW, Pullman ME (eds) Methods in enzymology, 10. Academic, New York, pp 213–215Google Scholar
  46. Tzagoloff, A., and Myers, A. M. (1986) Genetics of mitochondrial biogenesis. Annu Rev Biochem 55: 249–285Google Scholar
  47. Yonetani T (1967) Methods in Enzymology. In: Estrabrook RW, Pullman ME (eds) Cytochrome oxidase: beef heart. 10. Academic Press, New york, pp 332–335Google Scholar
  48. Young SD, Whissell M, Noble JC et al (2006) Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors. Clin Cancer Res 12(10):3092–3098CrossRefGoogle Scholar
  49. Yu L, Yu CA, King TE (1978) The indispensability of phospholipid and ubiquinone in mitochondrial electron transfer from succinate to cytochrome c. J Biol Chem 253:2657–2663Google Scholar
  50. Zhang JG, Lindup WE (1994) Cisplatin nephrotoxicity: decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem Pharmacol 47:1127–1135CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Centre for Biotechnology and Bioinformatics, School of Life SciencesJawaharlal Nehru Institute of Advanced Studies (JNIAS)SecunderabadIndia
  2. 2.Department of Biochemistry, School of Life SciencesUniversity of HyderabadHyderabadIndia

Personalised recommendations